亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北鑫源順醫藥化工有限公司  

沒有填寫主營業務~~

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:梁雨瑤
  • 電話:18062412635
  • QQ:1985589312
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 香草乙酮/4'-羥基-3-甲氧基苯乙酮498-02-2
香草乙酮/4'-羥基-3-甲氧基苯乙酮498-02-2
單價 100.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 5000kg起訂1kg
品牌 鑫源順
型號 USP/BP/EP/CP
規格 99%
過期 長期有效
更新 2012-09-11 16:08
 
詳細信息
香草乙酮/4'-羥基-3-甲氧基苯乙酮498-02-2
CAS號: 498-02-2
分子式: C9H10O3
分子量: 166.1739
外觀:類白色結晶性粉末
含量:99%
包裝:100g,500g,1kg,5kg,25kg/桶
用途:醫藥中間體
3,5-二羥基苯乙酮51863-60-6
CAS號: 51863-60-6
外觀:類白色結晶性粉末
含量:99%
包裝:100g,500g,1kg,5kg,25kg/桶
用途:醫藥中間體
恩他卡朋130929-57-6
(E)-2-氰基-3-(3,4二羥基-5-硝基苯)-N,N二乙基丙烯酰胺
分子式 C14H15N3O5
分子量  305.29
CAS號  130929-57-6
外觀:黃色粉末,熔點162--163
標準:USP33/BP2010/EP6.5
含量:99%-102%
干失:1.0%
水份:0.5%
包裝:25kg/桶
用途:為COMT抑制劑,用于治療帕金森病。

©2025 湖北鑫源順醫藥化工有限公司 版權所有   技術支持:化工網   訪問量:6238  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |